Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Type: Alert
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 251 items.
Health Canada is advising about unauthorized workout products that may pose serious health risks. The products are labelled to contain or have been tested and found to contain dangerous ingredients. Health Canada updates the table when it finds…
AlertPublic advisory | 2023-03-22
Health Canada is advising about unauthorized sexual enhancement products that may pose serious health risks. The products are labelled to contain or have been tested and found to contain dangerous ingredients. Health Canada updates the table when it…
AlertPublic advisory | 2023-03-21
In 2013, ISTODAX (romidepsin) was authorized under a Notice of Compliance with conditions (NOC/c) for the treatment of patients with relapsed/refractory peripheral T-cell lymphoma (PTCL) who are not eligible for transplant and have received at least one…
AlertHealth professional risk communication | 2023-03-20
Health Canada is advising the public that Gilead Sciences Incorporated recalled two lots (032168 and 033357) of the cystic fibrosis drug Cayston (aztreonam) (DIN 02329840) on March 1, 2023, due to the potential of cracked glass vials in those lots, which…
AlertPublic advisory | 2023-03-20
Canada is experiencing a shortage of nitroglycerin 0.4 MG/ACT sprays due to supply issues with the raw materials used to make the sprays as well as an increase in demand.
Nitroglycerin sublingual spray is applied under the tongue and is used to treat…
AlertPublic advisory | 2023-03-17
Health Canada is warning parents and caregivers about two unauthorized children's syrups for thinning mucus, Robikids and Solmux, seized from Kamshoppe, which advertised the products on Facebook. Both products are labelled to contain carbocisteine, a…
AlertPublic advisory | 2023-03-16
Health Canada is advising about unauthorized skin lightening products that may pose serious health risks. The products are labelled to contain or have been tested and found to contain dangerous ingredients. Health Canada updates the table when it finds…
AlertPublic advisory | 2023-03-06
Health Canada is warning consumers about unauthorized health products that it removed from sale from Kausch International Goods’ online Facebook store and its associated warehouse in Calgary, AB. The unauthorized products were labelled or previously…
AlertPublic advisory | 2023-03-01
Health Canada is warning consumers about an unauthorized health product, Kobayashi Eyebon Eye Wash, Cool format, which it seized from Oceanbuy, a store located in Markham ON, and removed from online sale. The unauthorized product was labelled in Japanese…
AlertPublic advisory | 2023-02-22
Health Canada seized unauthorized health products from two natural food stores in Sudbury, Ontario, because the products are labelled to contain prescription or controlled drugs, which may pose serious health risks.
The unauthorized products include…
AlertPublic advisory | 2023-02-20
Health Canada is warning consumers about an unauthorized health product, Solmux Carbocisteine Mucolytic, that it removed from sale from Palengke Pinoy, a retail store in Camrose, AB, and an online store on Facebook. This unauthorized product was…
AlertPublic advisory | 2023-02-17
Currently available data from the NOVA study, based on a data cut-off date of October 1, 2020, shows that the median OS may be lower with ZEJULA compared to placebo for patients in the overall non-gBRCAmut cohort and the non-gBRCAmut / Homologous…
AlertHealth professional risk communication | 2023-02-16
Health Canada is advising about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, as "…
AlertPublic advisory | 2023-02-10
UPDATE: February 7, 2023
One lot of APO-Amitriptyline recalled due to a nitrosamine impurity
Apotex Inc. is recalling one lot of APO-Amitriptyline (lot PY1904) 10 mg tablets due to the presence of N-nitrosodimethylamine (NDMA), a nitrosamine…
AlertPublic advisory | 2023-02-07
Health Canada is warning that intraocular lenses are not licensed to replace a patient’s natural, healthy lens (without cataracts) and that their use for this purpose comes with risks that may outweigh the benefits.
Entities such as surgical eye…
AlertPublic advisory | 2023-02-03